INTRODUCTION
The principal catabolic pathway for aliphatic diamines with three to six carbon atoms, their monoamino derivatives and histamine involves oxidation by diamine oxidase (EC 1.4.3.6). This enzyme, unevenly distributed in the organism, is involved in the terminal catabolism of polyamines, as are other copper-containing amine oxidases (Seiler et al., 1985) . Some observations suggest that diamine oxidase is responsible to a significant extent for putrescine catabolism in vivo (Sourkes & Missala, 1981) , even though in the brain monoamine oxidase (EC 1.4.3.4) assumes physiological importance in degrading the monoacetyl derivative of putrescine (Seiler & Al-Therib, 1974) .
Much of the early interest in diamine oxidase stemmed from the high enzyme activity found in physiological barriers (placenta, intestinal mucosa) , where it protects against elevated concentrations of amines produced by the fetus and intestinal bacteria and originating in the diet (Guha & Janne, 1976; Shaff & Beaven, 1976) . Another remarkable feature of diamine oxidase is that it increases in response to drugs and growthpromoting stimuli (Sessa et al., 1981; Desiderio et al., 1982; Perin et al., 1983) in tissues with low enzyme activity. In growing tissues, the increase in diamine oxidase activity is associated with an enhanced content of putrescine and other polyamines, and the inhibition of enzyme activity by aminoguanidine causes an increase in putrescine. Thus we suggested that the enhanced diamine oxidase activity in growth conditions may represent a means by which the excess of putrescine can be removed and the amounts of polyamines controlled (Perin et al., 1983 .
The regulation of diamine oxidase is quite complex, and a transcriptional mechanism with increased synthesis of mRNA, followed by new synthesis of enzyme protein, seems to be involved in tissues stimulated to grow or exposed to drugs Sessa et al., 1982 Sessa et al., , 1984 Perin et al., 1983) . A role of the 182-adrenoceptoradenylate cyclase system has been shown in normal and hypertrophic rat kidney by administration to rats of adrenergic agonists and antagonists, as well as of theophylline, an inhibitor of phosphodiesterase, or forskolin, an activator of adenylate cyclase (Desiderio et al., 1985) . Changes in cellular polyamine contents might represent another regulatory factor for diamine oxidase expression. In this regard, primary amines, including polyamines themselves, are known to control in cultured cells and in vivo the activity of ornithine decarboxylase (EC 4.1.1.17) (Kay & Lindsay, 1973; Janne & H6lttii, 1974; Clark & Fuller, 1975; Fong et al., 1976; Heller et al., 1976; Poso & Janne, 1976; Jefferson & Pegg, 1977; Kallio et al., 1977; Pegg et al., 1978) and S-adenosylmethionine decarboxylase (EC 4.1.1.50) (Pegg & Williams-Ashman, 1969; Pos6 & Pegg, 1981) , ratelimiting enzymes in polyamine biosynthesis, as well as spermidine Nl-acetyltransferase (Matsui et al., 1982) , the principal enzyme in polyamine interconversion.
In the present paper, we studied the relevance of tissue changes in polyamines on diamine oxidase activity in rats given putrescine, spermidine and their analogues. Male Wistar rats weighing 220-280 g were maintained on a 12 h-light/ 12 h-dark cycle and were given free access to food and water. All amines (750 ,mol/kg body wt.) were injected intraperitoneally between 09:00 and 10:00 h as a neutral solution in saline (0.9% NaCl) made up to a concentration so that the volume administered was 0.5 ml. Control animals received saline. Some putrescinetreated animals received contemporaneously an intraperitoneal injection of actinomycin D (2.5 mg/kg body wt.) or cycloheximide (2 mg/kg body wt.) in saline. Actinomycin D was dissolved by first warming in propylene glycol. All rats were killed by decapitation at various times after the treatments. Liver, kidney and heart were rapidly removed, weighed, frozen with solid CO2 and stored at -80°C until assayed, since tissue diamine oxidase activity is stable for several weeks under these conditions. Diamine oxidase activity assay Tissue samples were homogenized (20%, w/v) with a Potter apparatus in ice-cold 0.25 M-sucrose containing 0.3 mM-EDTA and 1 mM-2-mercaptoethanol. Diamine oxidase activity was assayed in homogenates by the method of Okuyama & Kobayashi (1961) , as described by Kusche et al. (1973) , which measures A1-[14C]pyrroline formedfrom [14C]putrescine. The assaymixturecontained, in a final volume of 0.75 ml, 150 ,mol of sodium/ potassium phosphate buffer, pH 7.4, homogenate (20 mg oftissue), saturating concentrations oflabelled putrescine (sp. radioactivity 0.167 Ci/mol) as substrate (300 nmol for liver, 600 nmol for kidney and heart) and 7.5,mol of acetaldehyde to exclude the interference of aldehydemetabolizing enzymes with Al-pyrroline formation (Sessa et al., 1981) . Assay blanks were prepared by incubation of samples in the presence of 40 pM-aminoguanidine, a specific inhibitor of diamine oxidase activity (Okuyama & Kobayashi, 1961 (Layne, 1957) .
Polyamine determination
Tissue samples, with addition of 1,8-diamino-octane dihydrochloride as internal standard, were homogenized (20%, w/v) in 0.2 M-HCl04, and supernatants, made alkaline (pH 9.5-10.5) with 1.5 M-Na2CO3 buffer, were dansylated (Igarashi et al., 1974) . The benzene extracts were evaporated and dissolved in methanol, and fluorescent polyamines were assayed by a Perkin-Elmer h.p.l.c. system (excitation at 368 nm and emission at 500 nm). The elution system consisted ofa linear gradient OI, putrescine; A, spermidine. made up of acetonitrile (A) and 4.2 mM-Na2HPO4 (B), which went from 50% (A) to 90% (A) in 12 min, followed by an isocratic period of 2 min. The flow rate was 1.8 ml/min.
Statistical analysis
The significance of the differences between the means was evaluated by Dunnett's (1955) test. The values were considered significant when P < 0.05.
RESULTS
Fig . 1 shows the behaviour of diamine oxidase activity and putrescine and spermidine contents in liver, kidney and heart from rats treated with a single dose of putrescine (750,umol/kg body wt.). In all the tissues studied, diamine oxidase activity increased significantly at 3-6 h after the injection by about 2-fold and began to decline thereafter, returning to basal values at 12 h. Shortly after putrescine injection (within 1 h), a marked enhancement in its tissue content was observed, 25-, Table 2 . Effect of diamine administration on diamine oxidase activity of some rat tissues 1,3-Diaminopropane, 1,5-diaminopentane or N-acetyl-1,4-diaminobutane was injected intraperitoneally at a dose of 750,umol/kg body wt., and the animals were killed at various times after diamine administration. Results are shown as the means+S.E.M. for the numbers of animals in parentheses: *P < 0.05, **P < 0.01 compared with saline-treated animals by Dunnett's (1955) putrescine decreased rapidly, especially in the kidney. The increase in putrescine concentrations was followed by a significant increase (1.4-fold) in spermidine, at 9 h in liver and at 6 h in kidney, whereas in the heart spermidine contents were unchanged. Spermine concentrations are not shown because they remained constant throughout the observations.
As reported in Table 1 , the inhibition of synthesis of mRNA and protein by actinomycin D or cycloheximide completely prevented the increase in diamine oxidase activity after putrescine administration. It is noteworthy that actinomycin D and cycloheximide did not significantly affect the basal diamine oxidase activity (A. Perin, A. Sessa & M. A. Desiderio, unpublished work) .
In further experiments, we tested the effect of structural analogues and derivatives of putrescine, given as a dose equimolar to putrescine, on hepatic, renal and myocardial diamine oxidase activity. The results reported in Table 2 show that 1,3-diaminopropane was active in stimulating enzyme activity at 3 h in kidney and at 6 h also in liver and heart, though to a lesser extent than putrescine. 1,5-Diaminopentane produced a lower diamine oxidase activity enhancement at 3 h and a similar one at 6 h than did putrescine. Monoacetylputrescine (N-acetyl-1,4-diaminobutane) caused the maximum increase in diamine oxidase activity at 3 h in liver and kidney, and at 4.5 h in heart, with values similar to those obtained with putrescine. Fig. 2 shows the accumulation of polyamines and the activity of diamine oxidase in liver, kidney and heart of rats treated with a fairly large but non-toxic dose of spermidine (750 ,umol/kg body wt.) (P6s6 & Pegg, 1981) . After 3 h, there was an increase in spermidine that led to an enhancement in putrescine content, with a maximum at 6 h, in accordance with Poso & Pegg (1981) and Matsui et al. (1982) . Putrescine increased about 11-fold in liver and 3-fold in heart, and the percentage increases were greater than those of spermidine, which only doubled at 3 h. In the kidney, putrescine enhancement was smaller (3-fold) than that of spermidine (8-fold), probably because this polyamine is concentrated in renal tissue before it is excreted into the urine (Matsui et al., 1982) . The peak values for hepatic, renal and cardiac diamine oxidase activity, which occurred at 9 h, were nearly 2-fold the basal values. Spermidine, putrescine and enzyme activity returned to normal values at 24 h. Spermine was not increased by the administration of spermidine and actually appeared to decrease slightly (results not shown).
The results reported in Table 3 show that the treatment with sym-norspermidine, the C. analogue of spermidine which cannot form putrescine, did not modify diamine oxidase activity in any of the studied tissues.
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DISCUSSION
The data obtained in this study show that liver, kidney and heart from putrescine-treated animals displayed an increase in diamine oxidase activity shortly after the enhancement in putrescine contents, indicating a possible interaction of these two events. Since putrescine is an immediate precursor of higher polyamines and in these experiments hepatic and renal spermidine was also enhanced, we emphasized the role of diamines by giving to rats some putrescine analogues, which are poor substrates for the aminopropyl transferase that forms spermidine, and thus are converted into polyamines to a very limited extent, if at all (Raina & Jiinne, 1975) . 1,5-Diaminopentane, a naturally occurring diamine (Tabor & Tabor, 1972) , was virtually as effective as putrescine in stimulating enzyme activity, whereas 1,3-diaminopropane, which is not physiological but is structurally closely related to putrescine, increased diamine oxidase activity to a minor extent. Additional information is necessary to elucidate whether the effects of putrescine analogues on diamine oxidase activity are direct or might be secondary to their action on the concentration of putrescine. Monoacetylputrescine, which is formed and degraded in hepatic and renal tissues (Seiler & Al-Therib, 1974) , enhanced, like putrescine, enzyme activity at 3 h in liver and kidney, but later in the heart, probably reflecting the different tissue rate of deacetylation to putrescine.
Experiments withexogenous higherpolyamines (spermidine and sym-norspermidine) support more convincingly the idea that putrescine is responsible for the enhancement in diamine oxidase activity. In spermidine-treated animals, the increase in enzyme activity took place when a substantial production of putrescine occurred, via conversion from spermidine (Matsui et al., 1982) . As could be expected, treatment with the unphysiological, but structurally closely related, sym-norspermidine, which is unable to form putrescine (P6s6 & Pegg, 1981) , did not increase diamine oxidase activity. The failure of spermidine itself to control diamine oxidase was also supported by the evidence that in the heart of putrescine-treated rats the activity of this enzyme increased even if spermidine contents were unchanged.
In conclusion, polyamines, known to regulate the principal enzymes of their biosynthesis and conversion (Pegg & Williams-Ashman, 1969; Kay & Lindsay, 1973; Janne & Holttii, 1974; Clark & Fuller, 1975; Fong et al., 1976; Heller et al., 1976; Poso & Jiinne, 1976; Jefferson & Pegg, 1977; Kallio et al., 1977; Pegg et al., 1978; Cameron et al., 1979; P6so & Pegg, 1981; Matsui et al., 1982) seem also to control diamine oxidase activity, an enzyme of their terminal catabolism, through the tissue contents of putrescine. This putrescine-mediated control involves new syntheses of mRNA and protein, probably with an enhanced expression of diamine oxidase or of a regulatory protein, which in turn may influence this enzyme. In the absence of cDNA probes and antibodies 
